The human body is governed by an ancient, rapid-response defense system. When an invader attacks, the innate immune system rushes to the front lines like firefighters to a blaze. But in a tiny baby boy named Isaac, the alarm bells started ringing for no reason at all, and the fire wouldn’t go out.
Isaac’s story began before he was even a week old. It started quietly—a mysterious rash blooming across his face and upper body before creeping down his back and legs. At first, doctors suspected a benign, fleeting newborn skin condition, the kind that naturally fades into a distant memory.
But Isaac’s rash didn’t fade. Instead, his body began to change in a way that defied standard medical textbooks.
As his mother, Ms. Hess, would later recall:
“His face and upper body got very thin. As time went on, his stomach began to look like he had a 12-pack.”
It was a baffling paradox: a baby growing sicker, yet developing an unnaturally chiseled, muscular-looking torso. What his family was witnessing was lipodystrophy—a progressive melting away of body fat.
Soon, a relentless fever took hold, burning for over a week. Desperate for answers, Isaac’s dermatologist referred him to UPMC Children’s Hospital of Pittsburgh. There, a small army of specialists—immunologists, geneticists, and rheumatologists—gathered around his case. They were playing a high-stakes game of elimination, ruling out known pathogens and common conditions while Isaac grew weaker.
Gradually, the clues pointed toward a dark corner of medicine: an autoinflammatory disease. Unlike autoimmune diseases, where the body creates specific antibodies to attack itself, autoinflammatory diseases mean the body’s innate, primitive immune system is simply stuck in an aggressive, overactive loop.
Isaac’s team realized his symptoms most closely resembled a medical phantom called CANDLE syndrome (Chronic Atypical Neutrophilic Dermatosis with Lipodystrophy and Elevated Temperature). It is a condition so exceptionally rare that fewer than 100 cases have ever been reported worldwide.
Yet, Isaac’s story carried a final, fascinating twist. Science loves neat boxes, but Isaac refused to fit into one. Children with CANDLE syndrome typically battle burning fevers almost daily; Isaac did not. Furthermore, when geneticists mapped his DNA, they found none of the standard genetic mutations associated with the syndrome.
He was a medical pioneer—a boy whose condition resembled CANDLE, but whose genetic code kept its own secrets.
Isaac’s journey at UPMC Children’s Hospital highlights the frontier of rare disease medicine, where definitive answers are scarce, and care must be meticulously tailored not to a textbook definition, but to the unique breathing child sitting on the examination table.
Fortunately, Isaac’s doctor had done some work in Candle like illnesses when he was at NIH, and could recommend a treatment called Baricitnib. Getting that treatment however was a marathon in itself.
“Getting Isaac on Baracitinib wasn’t easy — Ms. Hess says that the insurers refused to cover about five times. But his doctor was persistent. He sent literature, spoke to pharmacists, and engaged in peer-to-peer consultations, and finally convinced insurers to cover it. Today, Baracitinib seems to be working well for Isaac. His doctor estimates that Isaac might be one of 20 children on Baricitnib in the world.“
Source Note: All quotes and clinical timelines are adapted from the official patient history published by the UPMC Children’s Hospital of Pittsburgh Center for Rare Disease Therapy.
